OTS447
CAS No. 1356943-67-3
OTS447( —— )
Catalog No. M35684 CAS No. 1356943-67-3
OTS447 is a potent FLT3 inhibitor (IC50: 21 nM) with potential anticancer activity for cancer research .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 297 | In Stock |
|
| 10MG | 471 | In Stock |
|
| 25MG | 905 | In Stock |
|
| 50MG | 1423 | In Stock |
|
| 100MG | 2213 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOTS447
-
NoteResearch use only, not for human use.
-
Brief DescriptionOTS447 is a potent FLT3 inhibitor (IC50: 21 nM) with potential anticancer activity for cancer research .
-
DescriptionOTS447 is a potent FLT3 inhibitor with an IC50 of 21 nM (WO2012016082A1, compound 335).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
RecptorFLT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1356943-67-3
-
Formula Weight466.02
-
Molecular FormulaC27H32ClN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.41 mg/mL (26.63 mM; ultrasonic and warming and adjust pH to 2 with HCl and heat to 60°C)
-
SMILESCCN(CC)C1CCC(CC1)Nc1c(cnc2ccc(cc12)-c1ccc(O)c(Cl)c1)C(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yo Matsuo, et al. Quinoline derivatives and melk inhibitors containing the same. WO2012016082A1.
molnova catalog
related products
-
5'-Fluoroindirubinox...
5'-Fluoroindirubinoxime is a potent FLT3 inhibitor( IC50 : 15 nM).
-
Merestinib dihydroch...
Merestinib dihydrochloride (LY2801653 dihydrochloride) is an orally available kinase inhibitor with antitumor activity that inhibits MET, AXL, RON, and MKNK1/2, and inhibits the growth of NTRK fusion-carrying tumors.
-
AKN-028
AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor ( IC 50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation.
Cart
sales@molnova.com